D.E. Shaw & Co
ROIV icon

D.E. Shaw & Co’s Roivant Sciences ROIV Stock Holding History

D.E. Shaw & Co’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$38.6M Buy
1,392,748
+997,344
+252% +$25.6M 0.02% 778
2025
Q4 		$8.58M Sell
395,404
-152,655
-28% -$3.01M ﹤0.01% 1886
2025
Q3 		$8.29M Buy
548,059
+464,375
+555% +$5.75M ﹤0.01% 1825
2025
Q2 		$943K Buy
+83,684
New +$907K ﹤0.01% 3269
2023
Q1 		– Sell
-125,530
Closed -$1M – 4795
2022
Q4 		$1M Buy
+125,530
New +$698K ﹤0.01% 3452

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

D.E. Shaw & Co's ROIV Position: Q1 2026 in Review

D.E. Shaw & Co increased its Roivant Sciences (ROIV) stake by 252% in Q1 2026, buying an estimated $25.6M and bringing the position to 1,392,748 shares worth $38.6M. The position accounts for 0.02% of the portfolio, ranked #778.

D.E. Shaw & Co first reported a position in ROIV in Q4 2022 and has held it in 5 quarters since. 439 funds tracked by Wall St. Rank hold ROIV as of Q1 2026.

  • D.E. Shaw & Co held 1,392,748 shares of Roivant Sciences worth $38.6M as of Q1 2026.
  • D.E. Shaw & Co bought 997,344 Roivant Sciences shares in Q1 2026, an estimated $25.6M.
  • Roivant Sciences made up 0.02% of D.E. Shaw & Co's portfolio in Q1 2026, its #778 holding.
  • D.E. Shaw & Co first reported a position in Roivant Sciences in Q4 2022 and has held it in 5 quarters since.
  • 439 funds tracked by Wall St. Rank held Roivant Sciences as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.